Liquid Biopsy Evaluation Of Biomarkers In Various Clinical Specimen Types From Patient With Cancer

Liquid biopsy specimen collections will be obtained prospectively from multiple clinics for the evaluation of various non-blood bodily fluid sample types such as cerebrospinal fluid (CSF), pleural fluid, bronchial washings, ascites fluid, amniotic fluid, saliva, sputum, urine, etc.

The study is intended to assess the feasibility of interrogating these sample types for molecular profiling with Biocept Target Selector™ liquid biopsy methodologies that are either offered on the company’s current commercial test menu or are in development. Prospectively collected blood samples will also be collected from patients for the purpose of clinical validation of new Biocept Target Selector™ assays and/or cancer types that are not on the company’s current commercial test menu.